RARE - Ultragenyx Pharmaceutical Inc.
IEX Last Trade
56.78
-0.180 -0.317%
Share volume: 754,442
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$56.96
-0.18
-0.32%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-17 | 2023-05-05 | 2023-08-04 | 2023-11-03 | 2024-02-21 | 2024-05-03 | 2024-08-02 | |
| Cash flow financing | 491.877 M | 1.882 M | -722.000 K | 33.020 M | 25.234 M | 330.610 M | -58.000 K | 384.939 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -95.345 M | -90.342 M | -156.867 M | -116.161 M | -117.874 M | -83.904 M | -190.727 M | -76.963 M | |
| Net income | -245.106 M | -151.833 M | -163.972 M | -159.828 M | -159.649 M | -123.190 M | -170.684 M | -131.598 M | |
| Depreciation | 4.694 M | 4.957 M | 5.236 M | 5.361 M | 7.191 M | 8.218 M | 8.845 M | 8.862 M | |
| Changes in inventories | 21.849 M | 26.766 M | 26.616 M | 28.256 M | 31.802 M | 33.969 M | 35.907 M | 40.137 M | |
| Changes in receivables | 31.164 M | 40.445 M | 42.991 M | 70.523 M | 79.263 M | 73.390 M | 100.253 M | 105.982 M | |
| Investing Cashflow | -161.859 M | -171.599 M | 111.304 M | 99.418 M | 64.295 M | -107.017 M | 94.435 M | 60.564 M | |
| Net Borrowings | -959.655 M | -816.505 M | -696.729 M | -603.358 M | -488.123 M | -624.825 M | -459.807 M | -818.521 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -26.046 M | -56.970 M | -25.034 M | -16.438 M | -3.695 M | -1.600 M | -13.211 M | -4.509 M | |
| Cash Change | 888.675 M | 747.762 M | 629.354 M | 551.981 M | 442.094 M | 577.209 M | 412.080 M | 763.821 M |